← 產業報告目錄

Emollient Market by Type (Esters, Fatty Alcohols, Fatty Acids, Ethers, Silicones, and Other Types), Form (Solid, Liquid), Application (Skin Care, Hair Care, Deodorants, Oral Care, and Other Applications), and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-06-23頁數 276報告編號 CH9406

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global emollient market size is projected to reach USD 4.08 billion by 2030 from USD 3.03 billion in 2024, at a CAGR of 5.15%. The increasing popularity of moisturizers, lotions, and anti-aging skin care products is a primary factor boosting the demand for emollients and propelling the market growth. Emollients are vital in keeping skin hydrated, soft, smooth, and healthy-looking by replenishing the skin’s barrier. As consumers continue to look for products that will give them soft, radiant, and youthful-looking skin, especially in more developed regions like Europe and North America, cosmetic formulators are turning to innovative emollients to help deliver on these changing demands. This development, driven by trends toward skin wellness, clean beauty, and dermatologically tested products, increases the popularity of emollients in today’s formulations, making them essential in everyday skin care regimens. “Fatty alcohols segment accounted for the second-largest share of the emollient market in 2024.” The fatty alcohols segment held the second-largest share of the global emollient market, in terms of value, in 2024. Fatty alcohols, such as cetyl and stearyl alcohols, are becoming more widely employed for their occlusive properties. By retaining moisture and reducing transepidermal water loss (TEWL), skin hydration levels are increased, and skin resilience is improved, which is ideal for dry and sensitive skin formulations. As consumers increasingly seek solutions to support skin barrier health, the demand for products featuring barrier-strengthening ingredients has skyrocketed. Fatty alcohols not only provide visible softness and moisture, but they also support long-term skin conditioning. Their utility in dermatologically approved formulations, particularly within eczema-prone or aging skin creams and balms, keeps the momentum of their novel adoption rolling into the ever-booming skin care applications. “Liquid form is projected to be the fastest-growing segment in the global emollient market during the forecast period.” Liquid form is projected to be the fastest-growing segment in the global emollient market between 2025 and 2030. Liquid emollients are essential hair care formulations, especially for conditioners, serums, and scalp treatments. They help smooth down hair cuticles to combat frizz and add lubrication for easier combability and shine. Further, they gently moisturize the scalp without leaving pores clogged. This is an increasingly important benefit sought after by consumers in pursuit of healthier hair growth. As demand increases for multi-use hair oils and leave-ins, lighter, more fluid emollients are being incorporated for their nutrient and softening benefits without heaviness, particularly in naturally derived and silicone-free products. “Deodorants was the third-largest application segment of the emollient market, in terms of value, in 2024.” The deodorants segment was the third-largest application in the global emollient market, in terms of value, in 2024. Rising consumer preference for alcohol-free deodorants because of their skin-drying and stinging properties is escalating the need for alcohol-free products formulated with emollients. These deodorants enriched with emollients ensure a smooth application while delivering a soft, moisturized feel. Brands launching clean, vegan, or natural deodorants can use plant-based emollients such as shea butter, cocoa butter, or jojoba oil to improve glide and skin feel. With consumers increasingly focused on ingredient transparency and the health of their skin in the long term, emollients are playing a key role in creating effective deodorants, particularly within premium and environmentally friendly product ranges. “Asia Pacific was the second-largest region in the emollient market, in terms of value, in 2024.” Asia Pacific was the second-largest region in the emollient market in 2024. The growing middle-class population in markets such as China, India, Indonesia, and Vietnam is driving the demand for more affordable and effective personal care products with skin-nourishing actives. With an increase in disposable incomes, consumers are moving rapidly from basics to skincare and hair care products with high-quality emollient products such as esters, fatty alcohols, and natural oils. Growing urbanization and a higher general beauty awareness are additionally urging native manufacturers to innovate and introduce new emollient-rich lotions, serums, and creams designed to meet consumer demands. • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20% • By Designation: Directors - 50%, Managers - 30%, and Others - 20% • By Region: North America - 40%, Europe - 35%, Asia Pacific - 20%, and the Rest of the World – 5% The key players profiled in the report include BASF SE (Germany), Croda International plc (UK), Evonik Industries AG (Germany), Lubrizol Corporation (US), Clariant AG (Switzerland), Eastman Chemical Company (US), Ashland Inc. (US), Innospec Inc. (US), Lonza Group (Switzerland), and Stepan Company (US). Research Coverage This report segments the emollient market based on type, form, application, and region and provides estimations of value (USD million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the emollient market. Reasons to Buy this Report This research report is focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the emollient market, high-growth regions, and market drivers, restraints, and opportunities. The report provides insights into the following points: • Market Penetration: Comprehensive information on emollients offered by top players in the global market • Analysis of key drivers (growing consumer focus on skincare, increasing demand for natural and sustainable ingredients, and expansion of premium personal care segments), restraints (raw material price volatility and regulatory complexities and compliance costs), opportunities (expansion in emerging markets and advanced functional benefits), and challenges (balancing performance and sustainability as well as formulation complexity and compatibility issues) influencing the growth of the emollient market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the emollient market. • Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for emollients across regions. • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global emollient market • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the emollient market.
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS OF STUDY 27 1.3.3 YEARS CONSIDERED 30 1.3.4 CURRENCY CONSIDERED 31 1.3.5 UNIT CONSIDERED 31 1.4 STAKEHOLDERS 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY DATA 32 2.1.1.1 Key data from secondary sources 33 2.1.2 PRIMARY DATA 33 2.1.2.1 Key primary participants 33 2.1.2.2 Key industry insights 34 2.1.2.3 Breakdown of primary interviews 34 2.2 MARKET SIZE ESTIMATION 35 2.2.1 BOTTOM-UP APPROACH 35 2.2.2 TOP-DOWN APPROACH 37 2.3 DATA TRIANGULATION 38 2.4 GROWTH FORECAST 39 2.4.1 SUPPLY-SIDE ANALYSIS 40 2.4.2 DEMAND-SIDE ANALYSIS 40 2.5 RESEARCH ASSUMPTIONS 41 2.6 RESEARCH LIMITATIONS 42 2.7 RISK ASSESSMENT 42 3 EXECUTIVE SUMMARY 43 4 PREMIUM INSIGHTS 46 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EMOLLIENTS MARKET 46 4.2 EMOLLIENTS MARKET, BY REGION 46 4.3 EUROPE: EMOLLIENTS MARKET, BY APPLICATION AND COUNTRY 47 4.4 REGIONAL ANALYSIS: EMOLLIENTS MARKET, BY TYPE 47 4.5 EMOLLIENTS MARKET, BY COUNTRY 48 5 MARKET OVERVIEW 49 5.1 INTRODUCTION 49 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 50 5.2.1.1 Growing consumer focus on skin care 50 5.2.1.2 Increasing demand for natural and sustainable ingredients 51 5.2.1.3 Expansion of premium personal care segments 51 5.2.2 RESTRAINTS 51 5.2.2.1 Raw material price volatility 51 5.2.2.2 Regulatory complexities and compliance costs 52 5.2.3 OPPORTUNITIES 52 5.2.3.1 Expansion in emerging markets 52 5.2.3.2 Advanced functional benefits 53 5.2.4 CHALLENGES 53 5.2.4.1 Balancing performance and sustainability 53 5.2.4.2 Formulatory complexity and compatibility issues 53 5.3 PORTER'S FIVE FORCES ANALYSIS 54 5.3.1 THREAT OF NEW ENTRANTS 55 5.3.2 THREAT OF SUBSTITUTES 55 5.3.3 BARGAINING POWER OF SUPPLIERS 55 5.3.4 BARGAINING POWER OF BUYERS 55 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 56 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 56 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 56 5.4.2 BUYING CRITERIA 57 5.5 MACROECONOMIC OUTLOOK 58 5.5.1 GDP TRENDS AND FORECAST 58 6 INDUSTRY TRENDS 59 6.1 SUPPLY CHAIN ANALYSIS 59 6.1.1 RAW MATERIAL SUPPLIERS 60 6.1.2 MANUFACTURERS 60 6.1.3 DISTRIBUTION NETWORKS 60 6.1.4 END USERS 60 6.2 PRICING ANALYSIS 61 6.2.1 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS 61 6.2.2 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION 62 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 63 6.4 ECOSYSTEM ANALYSIS 64 6.5 CASE STUDY ANALYSIS 65 6.5.1 REVOLUTIONIZING CLEAN BEAUTY WITH PLANTASENS PRO LM 65 6.5.2 ELEVATING SKINCARE AESTHETICS THROUGH FORMULATION SCIENCE 66 6.6 TECHNOLOGY ANALYSIS 66 6.6.1 KEY TECHNOLOGIES 66 6.6.1.1 Esterification and hydrogenation technologies 66 6.6.1.2 Encapsulation and delivery systems 67 6.6.2 COMPLIMENTARY TECHNOLOGIES 67 6.6.2.1 Green chemistry and bio-based synthesis 67 6.7 TRADE ANALYSIS 67 6.7.1 IMPORT SCENARIO (HS CODE 3304) 68 6.7.2 EXPORT SCENARIO (HS CODE 3304) 69 6.8 REGULATORY LANDSCAPE 70 6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 6.8.2 REGULATORY FRAMEWORK 73 6.8.2.1 ISO 16128 – Guidelines for Natural and Organic Cosmetic Ingredients 73 6.8.2.2 Regulation (EC) No 1223/2009 – EU Cosmetic Products Regulation 74 6.9 KEY CONFERENCES AND EVENTS 74 6.10 INVESTMENT AND FUNDING SCENARIO 75 6.11 PATENT ANALYSIS 75 6.11.1 APPROACH 75 6.11.2 DOCUMENT TYPES 75 6.11.3 TOP APPLICANTS 78 6.11.4 JURISDICTION ANALYSIS 80 6.12 IMPACT OF 2025 US TARIFF – OVERVIEW 80 6.12.1 INTRODUCTION 80 6.12.2 KEY TARIFF RATES 81 6.12.3 PRICE IMPACT ANALYSIS 81 6.12.4 IMPACT ON COUNTRY/REGION 82 6.12.4.1 US 82 6.12.4.2 Europe 82 6.12.4.3 Asia Pacific 83 6.12.5 IMPACT ON APPLICATIONS 84 6.13 IMPACT OF AI/GEN AI ON EMOLLIENTS MARKET 85 7 EMOLLIENTS MARKET, BY TYPE 87 7.1 INTRODUCTION 88 7.2 ESTERS 90 7.2.1 OPTIMIZING ACTIVE DELIVERY WITH ESTERS TO DRIVE MARKET EXPANSION 90 7.3 FATTY ALCOHOLS 91 7.3.1 MULTIFUNCTIONALITY PROPERTY OF FATTY ALCOHOLS TO FUEL MARKET GROWTH 91 7.4 FATTY ACIDS 93 7.4.1 RISING PREFERENCE FOR NATURAL LIPIDS TO DRIVE MARKET GROWTH 93 7.5 ETHERS 95 7.5.1 ENHANCED SKIN DELIVERY CAPABILITIES TO FUEL MARKET EXPANSION 95 7.6 SILICONES 96 7.6.1 ENHANCED WATER RESISTANCE CAPABILITIES TO PROPEL MARKET 96 7.7 OTHER TYPES 98 8 EMOLLIENTS MARKET, BY PRODUCT TYPE 100 8.1 INTRODUCTION 100 8.2 CREAMS 100 8.3 LOTIONS 100 8.4 OINTMENTS 100 8.5 OILS 101 8.6 BUTTERS 101 8.7 BALMS & STICKS 101 8.8 GELS 101 8.9 SPRAYS & MISTS 102 9 EMOLLIENTS MARKET, BY SOURCE 103 9.1 INTRODUCTION 103 9.2 NATURAL 103 9.2.1 PLANT-DERIVED 103 9.2.2 ANIMAL-DERIVED 103 9.3 SYNTHETIC 104 9.3.1 PETROLEUM-BASED 104 9.3.2 LAB-SYNTHESIZED ESTERS 104 10 EMOLLIENTS MARKET, BY FORM 105 10.1 INTRODUCTION 106 10.2 LIQUID 107 10.2.1 ENHANCED SENSORY EXPERIENCE TO FUEL DEMAND 107 10.3 SOLID 109 10.3.1 STRUCTURE-BUILDING FUNCTIONALITY TO DRIVE MARKET DEMAND 109 11 EMOLLIENTS MARKET, BY FUNCTION 111 11.1 INTRODUCTION 111 11.2 SKIN CONDITIONING 111 11.3 BARRIER ENHANCEMENT 111 11.4 LUBRICATION 111 11.5 TEXTURE IMPROVEMENT 112 11.6 MOISTURIZATION 112   12 EMOLLIENTS MARKET, BY APPLICATION 113 12.1 INTRODUCTION 114 12.2 SKIN CARE 116 12.2.1 RISING DEMAND FOR MULTIFUNCTIONAL FORMULATIONS TO DRIVE MARKET GROWTH 116 12.3 HAIR CARE 117 12.3.1 ADVANCED HAIR REPAIR SOLUTIONS TO FUEL GROWTH OF SPECIALTY EMOLLIENTS 117 12.4 DEODORANTS 119 12.4.1 RISE IN CLEAN-LABEL DEODORANTS TO DRIVE MARKET GROWTH 119 12.5 ORAL CARE 121 12.5.1 INCREASING DEMAND FOR CLEAN-LABEL ORAL PRODUCTS TO BOOST MARKET DEMAND 121 12.6 OTHER APPLICATIONS 122 13 EMOLLIENTS MARKET, BY REGION 125 13.1 INTRODUCTION 126 13.2 ASIA PACIFIC 128 13.2.1 CHINA 134 13.2.1.1 Rise in domestic beauty brands with ingredient innovation to drive market 134 13.2.2 JAPAN 135 13.2.2.1 Sensory innovation in formulations to fuel growth 135 13.2.3 INDIA 137 13.2.3.1 Increasing penetration of affordable and personalized skin care products to drive market 137 13.2.4 SOUTH KOREA 139 13.2.4.1 Demand for glass skin aesthetics to boost market growth 139 13.3 NORTH AMERICA 140 13.3.1 US 146 13.3.1.1 Skin wellness trends to drive market growth 146 13.3.2 CANADA 148 13.3.2.1 Climate-resilient skincare needs to drive market 148 13.3.3 MEXICO 150 13.3.3.1 Expanding urbanization to support market growth 150 13.4 EUROPE 151 13.4.1 GERMANY 157 13.4.1.1 Strong industrial base to boost market 157 13.4.2 ITALY 159 13.4.2.1 Natural beauty traditions to drive ingredient usage 159 13.4.3 FRANCE 161 13.4.3.1 Strong heritage in luxury skincare to drive market 161   13.4.4 UK 162 13.4.4.1 Stringent regulatory framework to propel market 162 13.4.5 SPAIN 164 13.4.5.1 Climate-adaptive skincare routines to drive demand 164 13.4.6 POLAND 166 13.4.6.1 Demand for modern, well-formulated skincare to drive market 166 13.5 MIDDLE EAST & AFRICA 167 13.5.1 GCC COUNTRIES 173 13.5.1.1 Saudi Arabia 173 13.5.1.1.1 Rising demand for luxury beauty to drive market 173 13.5.2 TURKEY 175 13.5.2.1 Heritage beauty practices to drive market shift 175 13.5.3 IRAN 176 13.5.3.1 Rising demand for skin care to drive market 176 13.5.4 SOUTH AFRICA 178 13.5.4.1 Need for hydrating products to boost market growth 178 13.6 SOUTH AMERICA 180 13.6.1 BRAZIL 185 13.6.1.1 Rapidly expanding economy to boost market 185 14 COMPETITIVE LANDSCAPE 187 14.1 INTRODUCTION 187 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 187 14.3 MARKET SHARE ANALYSIS 188 14.4 REVENUE ANALYSIS OF TOP FIVE PLAYERS 191 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 192 14.5.1 STARS 192 14.5.2 EMERGING LEADERS 192 14.5.3 PERVASIVE PLAYERS 192 14.5.4 PARTICIPANTS 192 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 194 14.5.5.1 Company footprint 194 14.5.5.2 Region footprint 195 14.5.5.3 Form footprint 196 14.5.5.4 Type footprint 197 14.5.5.5 Application footprint 198 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 199 14.6.1 PROGRESSIVE COMPANIES 199 14.6.2 RESPONSIVE COMPANIES 199 14.6.3 DYNAMIC COMPANIES 199 14.6.4 STARTING BLOCKS 199   14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 200 14.6.5.1 Detailed list of key startups/SMES 200 14.6.5.2 Competitive benchmarking of key startups/SMEs 201 14.7 BRAND/PRODUCT COMPARISON ANALYSIS 202 14.8 COMPANY VALUATION AND FINANCIAL METRICS 203 14.9 COMPETITIVE SCENARIO 204 14.9.1 PRODUCT LAUNCHES 204 14.9.2 DEALS 206 14.9.3 EXPANSIONS 208 14.9.4 OTHER DEVELOPMENTS 209 15 COMPANY PROFILES 211 15.1 KEY PLAYERS 211 15.1.1 BASF SE 211 15.1.1.1 Business overview 211 15.1.1.2 Products offered 212 15.1.1.3 Recent developments 213 15.1.1.3.1 Product launches 213 15.1.1.3.2 Deals 214 15.1.1.3.3 Expansions 214 15.1.1.3.4 Other developments 214 15.1.1.4 MnM view 215 15.1.1.4.1 Key strengths 215 15.1.1.4.2 Strategic choices 215 15.1.1.4.3 Weaknesses & competitive threats 215 15.1.2 CRODA INTERNATIONAL PLC 216 15.1.2.1 Business overview 216 15.1.2.2 Products offered 217 15.1.2.3 Recent developments 218 15.1.2.3.1 Product launches 218 15.1.2.3.2 Deals 218 15.1.2.3.3 Expansions 219 15.1.2.3.4 Other developments 219 15.1.2.4 MnM view 220 15.1.2.4.1 Key strengths 220 15.1.2.4.2 Strategic choices 220 15.1.2.4.3 Weaknesses & competitive threats 220 15.1.3 EVONIK INDUSTRIES AG 221 15.1.3.1 Business overview 221 15.1.3.2 Products offered 222 15.1.3.3 Recent developments 223 15.1.3.3.1 Product launches 223 15.1.3.3.2 Deals 224 15.1.3.3.3 Expansions 224 15.1.3.3.4 Other developments 224 15.1.3.4 MnM view 225 15.1.3.4.1 Key strengths 225 15.1.3.4.2 Strategic choices 225 15.1.3.4.3 Weaknesses & competitive threats 225 15.1.4 CLARIANT AG 226 15.1.4.1 Business overview 226 15.1.4.2 Products offered 227 15.1.4.3 Recent developments 228 15.1.4.3.1 Product launches 228 15.1.4.3.2 Deals 229 15.1.4.3.3 Expansions 229 15.1.4.3.4 Other developments 229 15.1.4.4 MnM view 230 15.1.4.4.1 Key strengths 230 15.1.4.4.2 Strategic choices 230 15.1.4.4.3 Weaknesses & competitive threats 230 15.1.5 THE LUBRIZOL CORPORATION 231 15.1.5.1 Business overview 231 15.1.5.2 Products offered 231 15.1.5.3 Recent developments 232 15.1.5.3.1 Product launches 232 15.1.5.3.2 Deals 232 15.1.5.3.3 Expansions 233 15.1.5.3.4 Other developments 233 15.1.5.4 MnM view 233 15.1.5.4.1 Key strengths 233 15.1.5.4.2 Strategic choices 234 15.1.5.4.3 Weaknesses & competitive threats 234 15.1.6 EASTMAN CHEMICAL COMPANY 235 15.1.6.1 Business overview 235 15.1.6.2 Products offered 236 15.1.6.3 Recent developments 237 15.1.6.3.1 Product launches 237 15.1.6.3.2 Deals 237 15.1.6.3.3 Expansions 238 15.1.6.3.4 Other developments 238   15.1.7 ASHLAND INC. 239 15.1.7.1 Business overview 239 15.1.7.2 Products offered 240 15.1.7.3 Recent developments 241 15.1.7.3.1 Product launches 241 15.1.7.3.2 Deals 242 15.1.7.3.3 Expansions 242 15.1.8 INNOSPEC INC. 243 15.1.8.1 Business overview 243 15.1.8.2 Products offered 244 15.1.8.3 Recent developments 245 15.1.8.3.1 Product launches 245 15.1.8.3.2 Expansions 245 15.1.9 LONZA GROUP LTD. 246 15.1.9.1 Business overview 246 15.1.9.2 Products offered 247 15.1.10 STEPAN COMPANY 249 15.1.10.1 Business overview 249 15.1.10.2 Products offered 250 15.2 STARTUPS/SMES 252 15.2.1 KLK OLEO 252 15.2.2 SYENSQO SA/NV 253 15.2.3 GATTEFOSSÉ 253 15.2.4 SASOL LIMITED 254 15.2.5 DOW INC. 254 15.2.6 COVESTRO AG 255 15.2.7 VANTAGE SPECIALTY CHEMICALS 255 15.2.8 BERG+SCHMIDT GMBH & CO. KG 256 15.2.9 IOI OLEO GMBH 256 15.2.10 CARGILL, INC. 257 15.2.11 NOURYON 257 15.2.12 NIKKO CHEMICALS CO., LTD. 258 15.2.13 HALLSTAR 258 15.2.14 COLONIAL CHEMICAL, INC. 259 15.2.15 ELEMENTIS PLC 259 16 ADJACENT & RELATED MARKETS 260 16.1 INTRODUCTION 260 16.2 LIMITATION 260 16.3 PERSONAL CARE INGREDIENTS MARKET 260 16.3.1 MARKET DEFINITION 260 16.3.2 MARKET OVERVIEW 261 16.4 PERSONAL CARE INGREDIENTS MARKET, BY REGION 261 16.4.1 EUROPE 261 16.4.2 NORTH AMERICA 263 16.4.3 ASIA PACIFIC 264 16.4.4 MIDDLE EAST & AFRICA 265 16.4.5 SOUTH AMERICA 266 17 APPENDIX 268 17.1 DISCUSSION GUIDE 268 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 272 17.3 CUSTOMIZATION OPTIONS 274 17.4 RELATED REPORTS 274 17.5 AUTHOR DETAILS 275
圖表清單 List of Tables & Figures
TABLE 1 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY TYPE 27 TABLE 2 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY PRODUCT TYPE 28 TABLE 3 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY SOURCE 29 TABLE 4 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY FORM 29 TABLE 5 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY FUNCTION 29 TABLE 6 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY APPLICATION 30 TABLE 7 EMOLLIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 56 TABLE 8 IMPACT OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS (%) 57 TABLE 9 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 57 TABLE 10 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2021–2030 (USD BILLION) 58 TABLE 11 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG) 61 TABLE 12 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION, 2022–2030 (USD/KG) 62 TABLE 13 ROLE OF COMPANIES IN EMOLLIENTS ECOSYSTEM 64 TABLE 14 IMPORT DATA RELATED TO EMOLLIENTS, BY REGION, 2019–2024 (USD MILLION) 68 TABLE 15 EXPORT DATA RELATED TO EMOLLIENTS, BY REGION, 2019–2024 (USD MILLION) 69 TABLE 16 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 22 EMOLLIENTS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 74 TABLE 23 EMOLLIENTS MARKET: FUNDING/INVESTMENT SCENARIO, 2023–2025 75 TABLE 24 PATENT STATUS, 2014–2024 76 TABLE 25 LIST OF MAJOR PATENTS RELATED TO EMOLLIENTS, 2014–2024 78 TABLE 26 PATENTS BY COLGATE-PALMOLIVE COMPANY 79 TABLE 27 US ADJUSTED RECIPROCAL TARIFF RATES 81 TABLE 28 EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 88 TABLE 29 EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 89 TABLE 30 EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 89 TABLE 31 EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 89 TABLE 32 ESTERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 90 TABLE 33 ESTERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 90 TABLE 34 ESTERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 91 TABLE 35 ESTERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 91 TABLE 36 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 92 TABLE 37 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 92 TABLE 38 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 92 TABLE 39 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 93 TABLE 40 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 93 TABLE 41 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 94 TABLE 42 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 94 TABLE 43 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 94 TABLE 44 ETHERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 95 TABLE 45 ETHERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 95 TABLE 46 ETHERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 96 TABLE 47 ETHERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 96 TABLE 48 SILICONES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 97 TABLE 49 SILICONES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 97 TABLE 50 SILICONES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 97 TABLE 51 SILICONES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 98 TABLE 52 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 98 TABLE 53 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 98 TABLE 54 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 99 TABLE 55 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 99 TABLE 56 EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 106 TABLE 57 EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 106 TABLE 58 EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 107 TABLE 59 EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 107 TABLE 60 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 108 TABLE 61 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 108 TABLE 62 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 108 TABLE 63 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 109 TABLE 64 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 109 TABLE 65 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 110 TABLE 66 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 110 TABLE 67 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 110 TABLE 68 EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 114 TABLE 69 EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115 TABLE 70 EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 115 TABLE 71 EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 115 TABLE 72 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 116 TABLE 73 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 116 TABLE 74 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 117 TABLE 75 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 117 TABLE 76 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 118 TABLE 77 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 118 TABLE 78 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 118 TABLE 79 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 119 TABLE 80 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 119 TABLE 81 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 120 TABLE 82 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 120 TABLE 83 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 120 TABLE 84 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 121 TABLE 85 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 86 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 122 TABLE 87 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 122 TABLE 88 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 123 TABLE 89 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 90 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 123 TABLE 91 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 124 TABLE 92 EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 126 TABLE 93 EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 94 EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 127 TABLE 95 EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 127 TABLE 96 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 129 TABLE 97 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 129 TABLE 98 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2020–2024(KILOTON) 129 TABLE 99 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 130 TABLE 100 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 130 TABLE 101 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 130 TABLE 102 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 131 TABLE 103 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 131 TABLE 104 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 131 TABLE 105 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 131 TABLE 106 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 132 TABLE 107 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 132 TABLE 108 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 132 TABLE 109 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 133 TABLE 110 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 133 TABLE 111 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 133 TABLE 112 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 134 TABLE 113 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134 TABLE 114 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 135 TABLE 115 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 135 TABLE 116 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 136 TABLE 117 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 136 TABLE 118 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 136 TABLE 119 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 137 TABLE 120 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 137 TABLE 121 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 138 TABLE 122 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 138 TABLE 123 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 138 TABLE 124 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 139 TABLE 125 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 139 TABLE 126 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 140 TABLE 127 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 140 TABLE 128 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 141 TABLE 129 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 142 TABLE 130 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 142 TABLE 131 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 143 TABLE 132 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 143 TABLE 133 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 143 TABLE 134 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 143 TABLE 135 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 144 TABLE 136 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 144 TABLE 137 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144 TABLE 138 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 145 TABLE 139 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 145 TABLE 140 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 145 TABLE 141 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 145 TABLE 142 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 146 TABLE 143 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 146 TABLE 144 US: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 147 TABLE 145 US: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147 TABLE 146 US: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 147 TABLE 147 US: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148 TABLE 148 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024(USD MILLION) 148 TABLE 149 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 149 TABLE 150 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 149 TABLE 151 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 149 TABLE 152 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 150 TABLE 153 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 150 TABLE 154 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 151 TABLE 155 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 151 TABLE 156 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 152 TABLE 157 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 153 TABLE 158 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 153 TABLE 159 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 153 TABLE 160 EUROPE: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 154 TABLE 161 EUROPE: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 154 TABLE 162 EUROPE: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 154 TABLE 163 EUROPE: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 154 TABLE 164 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 155 TABLE 165 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155 TABLE 166 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 155 TABLE 167 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 156 TABLE 168 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 156 TABLE 169 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 156 TABLE 170 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 157 TABLE 171 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 157 TABLE 172 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 158 TABLE 173 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 158 TABLE 174 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 158 TABLE 175 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 159 TABLE 176 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 159 TABLE 177 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160 TABLE 178 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 160 TABLE 179 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 160 TABLE 180 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 161 TABLE 181 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 161 TABLE 182 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 162 TABLE 183 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 162 TABLE 184 UK: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 163 TABLE 185 UK: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 163 TABLE 186 UK: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 163 TABLE 187 UK: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 164 TABLE 188 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 164 TABLE 189 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 165 TABLE 190 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 165 TABLE 191 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 165 TABLE 192 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 166 TABLE 193 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 166 TABLE 194 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 167 TABLE 195 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 167 TABLE 196 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 168 TABLE 197 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 168 TABLE 198 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 168 TABLE 199 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 169 TABLE 200 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 169 TABLE 201 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 169 TABLE 202 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 170 TABLE 203 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 170 TABLE 204 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 170 TABLE 205 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 170 TABLE 206 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 171 TABLE 207 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 171 TABLE 208 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 171 TABLE 209 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 172 TABLE 210 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 172 TABLE 211 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 172 TABLE 212 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 173 TABLE 213 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 174 TABLE 214 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 174 TABLE 215 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 174 TABLE 216 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 175 TABLE 217 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 175 TABLE 218 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 176 TABLE 219 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 176 TABLE 220 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 177 TABLE 221 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 177 TABLE 222 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 177 TABLE 223 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 178 TABLE 224 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 178 TABLE 225 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 179 TABLE 226 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 179 TABLE 227 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 179 TABLE 228 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 180 TABLE 229 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 180 TABLE 230 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 181 TABLE 231 SOUTH AMERICA: EMOLLIENTS MARKET, TYPE, 2025–2030 (KILOTON) 181 TABLE 232 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 181 TABLE 233 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 181 TABLE 234 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 182 TABLE 235 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 182 TABLE 236 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 182 TABLE 237 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 183 TABLE 238 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 183 TABLE 239 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 183 TABLE 240 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 184 TABLE 241 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 184 TABLE 242 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 184 TABLE 243 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 184 TABLE 244 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 185 TABLE 245 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 185 TABLE 246 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 186 TABLE 247 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 186 TABLE 248 STRATEGIES ADOPTED BY KEY EMOLLIENT MANUFACTURERS, JANUARY 2020–MAY 2025 187 TABLE 249 EMOLLIENTS MARKET: DEGREE OF COMPETITION 189 TABLE 250 EMOLLIENTS MARKET: REGION FOOTPRINT 195 TABLE 251 EMOLLIENTS MARKET: FORM FOOTPRINT 196 TABLE 252 EMOLLIENTS MARKET: TYPE FOOTPRINT 197 TABLE 253 EMOLLIENTS MARKET: APPLICATION FOOTPRINT 198 TABLE 254 EMOLLIENTS MARKET: KEY STARTUPS/SMES 200 TABLE 255 EMOLLIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 201 TABLE 256 EMOLLIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 204 TABLE 257 EMOLLIENTS MARKET: DEALS, JANUARY 2020–MAY 2025 206 TABLE 258 EMOLLIENTS MARKET: EXPANSIONS, JANUARY 2020–MAY 2025 208 TABLE 259 EMOLLIENT MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2025 209 TABLE 260 BASF SE: COMPANY OVERVIEW 211 TABLE 261 BASF SE: PRODUCTS OFFERED 212 TABLE 262 BASF SE: PRODUCT LAUNCHES 213 TABLE 263 BASF SE: DEALS 214 TABLE 264 BASF SE: EXPANSIONS 214 TABLE 265 BASF SE: OTHER DEVELOPMENTS 214 TABLE 266 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 216 TABLE 267 CRODA INTERNATIONAL PLC: PRODUCTS OFFERED 217 TABLE 268 CRODA INTERNATIONAL PLC: PRODUCT LAUNCHES 218 TABLE 269 CRODA INTERNATIONAL PLC: DEALS 218 TABLE 270 CRODA INTERNATIONAL PLC: EXPANSIONS 219 TABLE 271 CRODA INTERNATIONAL PLC: OTHER DEVELOPMENTS 219 TABLE 272 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 221 TABLE 273 EVONIK INDUSTRIES AG: PRODUCTS OFFERED 222 TABLE 274 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES 223 TABLE 275 EVONIK INDUSTRIES AG: DEALS 224 TABLE 276 EVONIK INDUSTRIES AG: EXPANSIONS 224 TABLE 277 EVONIK INDUSTRIES AG: OTHER DEVELOPMENTS 224 TABLE 278 CLARIANT AG: COMPANY OVERVIEW 226 TABLE 279 CLARIANT AG: PRODUCTS OFFERED 227 TABLE 280 CLARIANT AG: PRODUCT LAUNCHES 228 TABLE 281 CLARIANT AG: DEALS 229 TABLE 282 CLARIANT AG: EXPANSIONS 229 TABLE 283 CLARIANT AG: OTHER DEVELOPMENTS 229 TABLE 284 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 231 TABLE 285 THE LUBRIZOL CORPORATION: PRODUCTS OFFERED 231 TABLE 286 THE LUBRIZOL CORPORATION: PRODUCT LAUNCHES 232 TABLE 287 THE LUBRIZOL CORPORATION: DEALS 232 TABLE 288 THE LUBRIZOL CORPORATION: EXPANSIONS 233 TABLE 289 THE LUBRIZOL CORPORATION: OTHER DEVELOPMENTS 233 TABLE 290 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW 235 TABLE 291 EASTMAN CHEMICAL COMPANY: PRODUCTS OFFERED 236 TABLE 292 EASTMAN CHEMICAL COMPANY: PRODUCT LAUNCHES 237 TABLE 293 EASTMAN CHEMICAL COMPANY: DEALS 237 TABLE 294 EASTMAN CHEMICAL COMPANY: EXPANSIONS 238 TABLE 295 EASTMAN CHEMICAL COMPANY: OTHER DEVELOPMENTS 238 TABLE 296 ASHLAND INC.: COMPANY OVERVIEW 239 TABLE 297 ASHLAND INC.: PRODUCTS OFFERED 240 TABLE 298 ASHLAND INC.: PRODUCT LAUNCHES 241 TABLE 299 ASHLAND INC.: DEALS 242 TABLE 300 ASHLAND INC.: EXPANSIONS 242 TABLE 301 INNOSPEC INC.: COMPANY OVERVIEW 243 TABLE 302 INNOSPEC INC.: PRODUCTS OFFERED 244 TABLE 303 INNOSPEC INC.: PRODUCT LAUNCHES 245 TABLE 304 INNOSPEC INC.: EXPANSIONS 245 TABLE 305 LONZA GROUP LTD.: COMPANY OVERVIEW 246 TABLE 306 LONZA GROUP: PRODUCTS OFFERED 247 TABLE 307 STEPAN COMPANY: COMPANY OVERVIEW 249 TABLE 308 STEPAN COMPANY: PRODUCTS OFFERED 250 TABLE 309 KLK OLEO: COMPANY OVERVIEW 252 TABLE 310 SYENSQO SA/NV: COMPANY OVERVIEW 253 TABLE 311 GATTEFOSSÉ: COMPANY OVERVIEW 253 TABLE 312 SASOL LIMITED: COMPANY OVERVIEW 254 TABLE 313 DOW INC.: COMPANY OVERVIEW 254 TABLE 314 COVESTRO AG: COMPANY OVERVIEW 255 TABLE 315 VANTAGE SPECIALTY CHEMICALS: COMPANY OVERVIEW 255 TABLE 316 BERG+SCHMIDT GMBH & CO. KG: COMPANY OVERVIEW 256 TABLE 317 IOI OLEO GMBH: COMPANY OVERVIEW 256 TABLE 318 CARGILL, INC.: COMPANY OVERVIEW 257 TABLE 319 NOURYON: COMPANY OVERVIEW 257 TABLE 320 NIKKO CHEMICALS CO., LTD.: COMPANY OVERVIEW 258 TABLE 321 HALLSTAR: COMPANY OVERVIEW 258 TABLE 322 COLONIAL CHEMICAL, INC.: COMPANY OVERVIEW 259 TABLE 323 ELEMENTIS PLC: COMPANY OVERVIEW 259 TABLE 324 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 261 TABLE 325 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 262 TABLE 326 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 262 TABLE 327 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 262 TABLE 328 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 263 TABLE 329 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 263 TABLE 330 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 263 TABLE 331 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 263 TABLE 332 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 264 TABLE 333 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 264 TABLE 334 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 264 TABLE 335 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 265 TABLE 336 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 265 TABLE 337 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 265 TABLE 338 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 266 TABLE 339 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 266 TABLE 340 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 266 TABLE 341 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 267 TABLE 342 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 267 TABLE 343 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 267 FIGURE 1 EMOLLIENTS MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 EMOLLIENTS MARKET: RESEARCH DESIGN 32 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE): COLLECTIVE MARKET SHARE OF KEY PLAYERS 35 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 - BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF ALL PRODUCTS 36 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 – BOTTOM-UP (DEMAND SIDE) 37 FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 4 - TOP-DOWN 37 FIGURE 7 EMOLLIENTS MARKET: DATA TRIANGULATION 39 FIGURE 8 MARKET CAGR PROJECTIONS FROM SUPPLY SIDE 40 FIGURE 9 MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS AND OPPORTUNITIES 41 FIGURE 10 ESTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 43 FIGURE 11 LIQUID FORM TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 44 FIGURE 12 SKIN CARE SEGMENT TO DOMINATE EMOLLIENTS MARKET IN 2025 44 FIGURE 13 EUROPE ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45 FIGURE 14 RISING USE OF MULTIFUNCTIONAL INGREDIENTS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 46 FIGURE 15 EUROPE TO DOMINATE EMOLLIENTS MARKET DURING FORECAST PERIOD 46 FIGURE 16 SKIN CARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN EMOLLIENTS MARKET IN 2024 47 FIGURE 17 ESTERS SEGMENT DOMINATED EMOLLIENTS MARKET ACROSS ALL REGIONS IN 2024 47 FIGURE 18 INDIA TO BE FASTEST-GROWING EMOLLIENTS MARKET DURING FORECAST PERIOD 48 FIGURE 19 EMOLLIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50 FIGURE 20 EMOLLIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 54 FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 56 FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 57 FIGURE 23 EMOLLIENTS MARKET: SUPPLY CHAIN ANALYSIS 59 FIGURE 24 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS FOR MAJOR APPLICATIONS, 2024 61 FIGURE 25 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION, 2022–2030 (USD/KG) 62 FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 63 FIGURE 27 EMOLLIENT MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 28 IMPORT DATA FOR EMOLLIENTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 68 FIGURE 29 EXPORT DATA FOR EMOLLIENTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 69 FIGURE 30 PATENTS REGISTERED FOR EMOLLIENTS, 2014–2024 76 FIGURE 31 MAJOR PATENTS RELATED TO EMOLLIENTS, 2014–2024 77 FIGURE 32 LEGAL STATUS OF PATENTS FILED RELATED TO EMOLLIENTS, 2014–2024 79 FIGURE 33 MAXIMUM PATENTS FILED IN JURISDICTION OF US, 2014–2024 80 FIGURE 34 IMPACT OF AI/GEN AI ON EMOLLIENTS MARKET 85 FIGURE 35 ESTERS SEGMENT TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 88 FIGURE 36 LIQUID FORM SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 106 FIGURE 37 SKIN CARE SEGMENT TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 114 FIGURE 38 EUROPE TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 126 FIGURE 39 ASIA PACIFIC: EMOLLIENTS MARKET SNAPSHOT 128 FIGURE 40 NORTH AMERICA: EMOLLIENTS MARKET SNAPSHOT 141 FIGURE 41 EUROPE: EMOLLIENTS MARKET SNAPSHOT 152 FIGURE 42 EMOLLIENTS MARKET SHARE ANALYSIS OF TOP FIVE PLAYERS, 2024 189 FIGURE 43 EMOLLIENTS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD MILLION) 191 FIGURE 44 EMOLLIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 193 FIGURE 45 EMOLLIENTS MARKET: COMPANY FOOTPRINT 194 FIGURE 46 EMOLLIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 200 FIGURE 47 BRAND/PRODUCT COMPARISON 202 FIGURE 48 EMOLLIENTS MARKET: EV/EBITDA OF KEY MANUFACTURERS 203 FIGURE 49 EMOLLIENTS MARKET: ENTERPRISE VALUATION OF KEY PLAYERS 203 FIGURE 50 BASF SE: COMPANY SNAPSHOT 212 FIGURE 51 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 217 FIGURE 52 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 222 FIGURE 53 CLARIANT AG: COMPANY SNAPSHOT 227 FIGURE 54 EASTMAN CHEMICAL COMPANY.: COMPANY SNAPSHOT 236 FIGURE 55 ASHLAND INC.: COMPANY SNAPSHOT 240 FIGURE 56 INNOSPEC INC.: COMPANY SNAPSHOT 244 FIGURE 57 LONZA GROUP LTD.: COMPANY SNAPSHOT 247 FIGURE 58 STEPAN COMPANY: COMPANY SNAPSHOT 250

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們